ClinicalTrials.Veeva

Menu

PRESERFLO® MicroShunt Extension Study

I

InnFocus

Status

Completed

Conditions

Primary Open-angle Glaucoma

Treatments

Device: PRESERFLO® MicroShunt
Procedure: Trabeculectomy

Study type

Observational

Funder types

Industry

Identifiers

NCT04333433
INN005 - EXT

Details and patient eligibility

About

This prospective, concurrent controlled, open-label, multicenter study is designed to collect additional safety data through 5 years of follow-up for subjects randomized to either the treatment arm (PRESERFLO® MicroShunt with MMC) or the control arm (Trabeculectomy with MMC) of the INN-005 clinical study.

Full description

The objective of this study is to evaluate the long-term safety of the PRESERFLO® MicroShunt in subjects with Primary Open-Angle Glaucoma who have completed their Month 24 Follow-Up Visit in the INN-005 clinical study, by collecting safety data through 5 years post-operative follow-up.

Enrollment

279 patients

Sex

All

Ages

40 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subject has completed their Month 24 Follow-Up Visit in the INN-005 clinical study conducted under IDE G130028.
  2. Subject was randomized into the INN-005 study and received the PRESERFLO® MicroShunt device or trabeculectomy. (Subjects who have had the device explanted, or replaced with another device, may be included).
  3. Subject is willing and able to comply with all study requirements, including signing an informed consent form.

Exclusion criteria

  1. Subject has exceeded the timeframe for the Month 60 Follow-Up Visit prior to enrollment for participation in this long-term follow-up study.

Trial design

279 participants in 2 patient groups

MicroShunt treatment group
Description:
Subjects previously randomized to this arm in pivotal study conducted under IDE G130028 were implanted with the device
Treatment:
Device: PRESERFLO® MicroShunt
Trabeculectomy control arm
Description:
Subjects previously randomized to this arm in pivotal study conducted under IDE G130028 underwent trabeculectomy procedure
Treatment:
Procedure: Trabeculectomy

Trial documents
2

Trial contacts and locations

23

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems